Questions for Prostate Cancer | 
RealOne Player | 
Windows Player |
 |
| 1. | What should I do with a patient with PSA greater than 5 but with a very normal DRE? |  | |
|
| 2. | What are the PSA levels for cancer and pre-cancerous conditions? | | |
|
| 3. | A patient with a PSA of 4.1 had a biopsy that showed PIN. What is the next step in the management of this patient? | | |
|
| 4. | Which patients would you recommend using finasteride for prevention of prostate cancer and BPH? | | |
|
| 5. | In the Prostate Cancer Prevention Trial, did the drug make a difference in patients with clinically significant versus low-grade cancer? | | |
|
| 6. | A 50-year-old man has a PSA of 11. After a three-week treatment with antibiotics, the PSA was 4.5. Is this an indication for a biopsy? | | |
|
| 7. | Do we recommend putting patients who have multiple factors for prostate cancer on finasteride ? | | |
|
| 8. | Which patients are the best candidates for finasteride for prevention of prostate cancer and what dose should we start with? Should we pay closer attention to patients with a PSA that is greater than 4, family history or race to go ahead and start treatment? If so which dose should we start at? | | |
|
| 9. | Should African-Americans be tested younger than age 45 and does it depend on other types of risk factors that they may have? | | |
|
| 10. | What should we do for asymptomatic patients with normal DRE but whose PSA tests comes back at six? | | |
|
| 11. | How do you choose between surgical versus radiotherapy for treatment of prostate cancer? | | |
|
| 12. | Is the greater incidence of prostate cancer in African-American more likely to be genetic, environmental or dietary factors? | | |
|
| 13. | Why does USTFPS not recommend PSA for screening? | | |
|
| 14. | What do we do with asymptomatic patients with PSA levels of greater than four but less than ten? | | |
|
| 15. | Where do we stand in terms of checking PSA levels? How often, what age should we start and do we screen asymptomatic patients or just those with symptoms? Are there other factors to consider with PSA scores other than age? | | |
|
| 16. | Are most early disease prostate cancer patients cured by therapy, radiation or surgery because disease was not initially lethal? | | |
|
| 17. | What is the correlation between BPH and prostate cancer and should we consider a specific patient population for preventative therapy of BPH and cancer with finasteride and alpha-blockers? | | |
|
| 18. | By how much do the various medical therapies affect PSA values? | | |
|
| 19. | At what age should we begin conducting DRE's on our patients? Should we do DRE's on asymptomatic patients? How large a nodule do you look for during a DRE? | | |
|
| 20. | Does DRE falsely elevate PSA values? If so, how long should one wait after DRE to obtain a PSA value? | | |
|
| 21. | For how long, how many years and how many times should the PSA Velocity Test be used? | | |
|
| 22. | In the PCPT trial, how did the subset of participants with a positive family history for prostate cancer respond to finasteride treatment? | | |
|
| 23. | At what age do we stop doing DRE and PSA? | | |
